Bicara Therapeutics (BCAX) Institutional Ownership

During the previous two years, 75 institutional investors and hedge funds held shares of Bicara Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($177.17M), FMR LLC ($57.91M), Red Tree Management LLC ($55.23M), Siren L.L.C. ($42.57M), Vestal Point Capital LP ($36.08M), Deep Track Capital LP ($34.84M), and Braidwell LP ($28.18M).Learn more on BCAX's institutional investors.

Of the 73 institutional investors that purchased Bicara Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($6.96M), Red Tree Management LLC ($3.17M), Vestal Point Capital LP ($2.77M), FMR LLC ($2.27M), Braidwell LP ($2.16M), Wellington Management Group LLP ($1.40M), and Adage Capital Partners GP L.L.C. ($1.38M).

Institutional investors have bought a total of 29,999,517 shares in the last 24 months. This purchase volume represents approximately $633.31M in transactions.

Of the 9 institutional investors that sold Bicara Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Adage Capital Partners GP L.L.C. ($992.37K), Janus Henderson Group PLC ($324.35K), Goldman Sachs Group Inc. ($54.05K), Maven Securities LTD ($25K), Wellington Management Group LLP ($11.95K), Siren L.L.C. ($5.74K), and Charles Schwab Investment Management Inc. ($3.78K).

Institutional investors have sold a total of 1,420,608 shares in the last 24 months. This volume of shares sold represents approximately $20.11M in transactions.